Physician profile
Munzer M Arnouk
NPI 1841271939
$1,309.99
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $97.43 · 2021: $299 · 2022: $177.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $233.73 | 2019-2021 | |
| Welch Allyn | $164.74 | 2021 | |
| Abbvie INC. | $149.38 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $125.41 | 2019 | |
| Baxter Healthcare | $109.82 | 2022 | |
| Lilly USA, LLC | $67.59 | 2019-2020 | |
| Glaxosmithkline, LLC. | $55.49 | 2019-2022 | |
| Allergan, INC. | $52.73 | 2019-2020 | |
| Amgen INC. | $42.27 | 2019 | |
| Astellas Pharma US INC | $39.61 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.85 | 2019-2022 | |
| Amarin Pharma, INC. | $28.76 | 2019 | |
| Pfizer INC. | $27.47 | 2019-2020 | |
| Novo Nordisk INC | $27.36 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $26.95 | 2019 | |
| Arbor Pharmaceuticals, INC. | $26.95 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.59 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $13.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.93 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Munzer Arnouk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.